Will New England See Lower Prices from Drug Pricing Transparency Legislation?

This report finds that most new drug pricing transparency laws do not lower consumer out-of-pocket costs, and that expensive and onerous compliance rules would likely put upward pressure on prices. The report reviews recent New England legislative attempts to reduce costs by requiring the disclosure of wholesale drug prices and other information about industry pricing practices.

Download Report: Will New England See Lower Prices from Drug Pricing Transparency Legislation?